4/A//SEC Filing
Hoverman Daniel S. 4/A
Accession 0001493152-19-003379
CIK 0001362703other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:57 PM ET
Size
8.1 KB
Accession
0001493152-19-003379
Insider Transaction Report
Form 4/AAmended
Hoverman Daniel S.
Director
Transactions
- Award
Stock Option (right to buy)
2018-05-09+3,000,000→ 3,000,000 totalExercise: $0.01From: 2019-05-09Exp: 2028-05-09→ Common Stock (3,000,000 underlying) - Award
Stock Option (right to buy)
2017-04-17+350,000→ 350,000 totalExercise: $0.27From: 2018-04-17Exp: 2027-04-17→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]Options issued as compensation approved by the Issuer's Board of Directors.
- [F2]This form is being amended because the original Form 4 aggregated the two grants listed above as the same class of options, when they are actually two separate classes.
Documents
Issuer
OncBioMune Pharmaceuticals, Inc
CIK 0001362703
Entity typeother
Related Parties
1- filerCIK 0001665931
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:57 PM ET
- Size
- 8.1 KB